I received my training in basic science and clinical research abroad, first (1995) at the New York University, (New York City, USA) and later (1998 – 2001) at the Harvard Medical School, (Boston, USA).
During this time I set the fundamentals of my research activities that I later continued to develop in Italy at the University of Pisa. In Pisa I founded the Molecular and Cellular Gynecological Endocrinology Laboratory (MCGEL), an international excellence center devoted to cutting-edge bio-molecular research on the mechanisms of action of reproductive hormones’ receptors at the level of the cardiovascular system, on female cancers and on the central nervous system. My research team has contributed fundamental advancements in the understanding of how reproductive hormones act on woman’s health as well as on aging-related diseases.
I also perform clinical and translational studies on endometriosis, on the role of nitric oxide in pregnancy, on innovative surgical techniques for the reconstruction of complex pelvic floor defects and for benign and oncological gynecologic surgery, on computer-assisted surgery and robotic mini-invasive surgery. I coordinate for the University of Pisa the Vita Nova project, financed with nearly 2 millions Euro from the Tuscan regional government, for the creation of an innovative application for smartphones and tablets dedicated to women approaching menopause.
In collaboration with International key opinion leaders and Scientific Societies I have published a long series of “position statements” and international guidelines dedicated to the Best Medical Practice for the diagnosis and management of important female diseases.
I have published over 150 original papers on high-impact international Journals, with a total Impact Factor over 550 and an H index of 32. My work has been cited by others more than 5.000 times.
To see my scientific publications follow this link
I am Editor of several International Journals, including: Maturitas, the Journal of Endocrinological Investigation, Faculty of a 1000 Women’s Health, Vascular Pharmacology, Frontiers in Cancer Endocrinology.
I am continuously invited to speak to the main Scientific Congresses in the area of Obstetrics and Gynecology worldwide. Within the various congresses, I have been an invited speakers at the congresses of the US Endocrine Society, at the European Molecular Biology Organization (EMBO) Congress, at the World Congress on the Menopause (IMS) and at the Congress of the Federation of International Societies of Gynecology and Obstetrics (FIGO).